These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 803558

  • 21. Effects of diphenylhydantoin (DPH) on distal colon motility.
    Lechin F, van der Dijs B.
    Acta Gastroenterol Latinoam; 1979; 9(3):145-52. PubMed ID: 532529
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The effect of diphenylhydantoin (phenytoin) on the sequential stages of intestinal folate absorption.
    Nelson EW, Crick WF, Cerda JJ, Wilder BJ, Streiff RR.
    Drug Nutr Interact; 1983; 2(1):47-56. PubMed ID: 6689591
    [Abstract] [Full Text] [Related]

  • 24. Enhancement of diphenylhydantoin binding by lipid extraction.
    Goldberg MA, Todoroff T.
    J Pharmacol Exp Ther; 1976 Mar; 196(3):579-85. PubMed ID: 1263113
    [Abstract] [Full Text] [Related]

  • 25. Influences on the absorption of diphenylhydantoin preparations.
    Windorfer A, Stünkel S, Weimann HM.
    Neuropadiatrie; 1978 May; 9(2):120-6. PubMed ID: 581216
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effectiveness of prednisolone during phenytoin therapy.
    Petereit LB, Meikle AW.
    Clin Pharmacol Ther; 1977 Dec; 22(6):912-6. PubMed ID: 923186
    [Abstract] [Full Text] [Related]

  • 28. Interaction of diphenylhydantoin (DPH) and tolbutamide in man.
    Wesseling H, Mols-Thürkow I.
    Eur J Clin Pharmacol; 1975 Dec; 8(1):75-8. PubMed ID: 1233204
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effect of diphenylhydantoin and its main hydroxylated metabolite on the pharmacokinetics and the urinary and biliary excretion of phenobarbital and its p-hydroxy metabolite.
    Sarhan F, Engasser JM, Batt AM, Magdalou J, Siest G.
    Eur J Drug Metab Pharmacokinet; 1981 Dec; 6(2):99-108. PubMed ID: 7306277
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man.
    Svendsen TL, Kristensen MB, Hansen JM, Skovsted L.
    Eur J Clin Pharmacol; 1976 Mar 22; 09(5-6):439-41. PubMed ID: 971708
    [Abstract] [Full Text] [Related]

  • 35. Effects of aspirin on salivary and serum phenytoin kinetics in healthy subjects.
    Paxton JW.
    Clin Pharmacol Ther; 1980 Feb 22; 27(2):170-8. PubMed ID: 7353335
    [Abstract] [Full Text] [Related]

  • 36. Comparative drug elimination in man-diphenylhydantoin and amobarbital.
    Brien JF, Inaba T, Kalow W.
    Eur J Clin Pharmacol; 1975 Oct 10; 9(1):79-83. PubMed ID: 1233257
    [Abstract] [Full Text] [Related]

  • 37. Diphenylhydantoin inhibition of pentagastrin-stimulated calcitonin secretion in the pig.
    Pento JT.
    Horm Metab Res; 1976 Sep 10; 8(5):399-401. PubMed ID: 976938
    [Abstract] [Full Text] [Related]

  • 38. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L, Kristensen M, Hansen M, Siersbaek-Nielsen K.
    Acta Med Scand; 1976 Sep 10; 199(6):513-5. PubMed ID: 59517
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.